Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
28,862,345
-
Total 13F shares
-
4,774,442
-
Share change
-
-349,976
-
Total reported value
-
$130,211,908
-
Price per share
-
$27.28
-
Number of holders
-
64
-
Value change
-
-$9,544,548
-
Number of buys
-
3
-
Number of sells
-
1
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2013
As of 31 Dec 2013,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,774,442 shares.
The largest 10 holders included
FMR LLC, Consonance Capital Management LP, FRANKLIN RESOURCES INC, WALL STREET ASSOCIATES, AlpInvest Partners B.V., SENZAR ASSET MANAGEMENT, LLC, BARCLAYS PLC, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, and BlackRock Fund Advisors.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.